艾司氯胺酮缓解剖宫产术中牵拉痛的ED50和ED95研究OA
The ED50 and ED95 of S-ketamine for alleviating visceral traction pain during cesarean section
目的 探讨单次静脉注射艾司氯胺酮缓解剖宫产术中牵拉痛的半数有效剂量(ED50)和95%有效剂量(ED95),为临床麻醉精准用药提供参考.方法 选择2024年4~11月广东省妇幼保健院在腰硬联合阻滞下拟行剖宫产术的产妇27例,年龄22~40岁,体质量指数(BMI)18~28 kg/m2,美国麻醉医师协会(ASA)分级Ⅱ或Ⅲ级.麻醉方式选择腰硬联合阻滞,应用Dixon上下序贯法进行试验,设定艾司氯胺酮的起始剂量为0.2 mg/kg,剂量梯度为0.05 mg/kg.若给予艾司氯胺酮后牵拉痛无效缓解则设定为阳性反应,下一位产妇的给药剂量增加一个梯度,反之牵拉痛有效缓解则设定为阴性反应,下一位产妇的给药剂量减少一个梯度,当出现8 个阳性-阴性反应交叉点时停止试验.记录术中牵拉痛的缓解情况,观察入室平静后(T0)、麻醉后 5 min(T1)、给药前(T2)、给药后 5 min(T3)、给药后10 min(T4)、手术结束时(T5)的心率、血压和脉搏血氧饱和度的变化;记录T5 时Ramsay 镇静评分、新生儿结局、产妇术后情况以及不良反应.采用 Probit 概率单位回归法计算艾司氯胺酮的 ED50 和 ED95.结果 艾司氯胺酮缓解剖宫产术中牵拉痛的 ED50 及 95%CI 为 0.151 mg/kg(95%CI 0.114~0.184 mg/kg);ED95 及95%CI为 0.226 mg/kg(95%CI 0.190~0.411 mg/kg).与T0 时比较,T1 时心率升高而 T5 时心率下降(P<0.05);T1 时血压低于T0 时血压,T3 时血压高于T1、T4 和T5 时血压(P<0.05).27名新生儿娩出后0、5、10 min的Apgar评分均为9、10、10分,脐静脉血气分析显示 pH 值为(7.35±0.04).统计例数中无严重不良反应发生.结论 通过 Dixon 上下序贯法和Probit 概率单位回归法测量单次静脉注射艾司氯胺酮用于缓解剖宫产术中牵拉痛的 ED50 及 95%CI 是 0.151 mg/kg(0.114~0.184 mg/kg),ED95 及95%CI是0.226 mg/kg(0.190~0.411 mg/kg),可为临床精准用药提供参考.
Objective To explore the median effective dose(ED50)and 95%effective dose(ED95)of a single intravenous injection of esketamine for alleviating visceral traction pain during cesarean section,providing a reference for precise medication in clinical anesthesia.Methods A total of 27 pregnant women,aged 22-40 years,with body mass index(BMI)18-28 kg/m2,of American Society of Anesthesiologists(ASA)physical status Ⅱ or Ⅲ,who were scheduled for cesarean section in Guangdong Women and Children Hospital from April to November were enrolled.The anesthesia method chosen was combined spinal-epidural anesthesia,and the Dixon up-and-down method was used for the trial.The initial dose of esketamine was set at 0.2 mg/kg,with a dose gradient of 0.05 mg/kg.If there was no effective relief of traction pain after administering esketamine,it was set as a positive response,and the dose for the next patient was increased by one gradient;conversely,if there was effective relief,it was set as a negative response,and the dose for the next patient was decreased by one gradient.The trial was stopped when eight positive-negative response crossover points were reached.The primary outcome was the relief of traction pain during surgery.The secondary outcomes mainly included recording heart rate,blood pressure,and SpO2 at rest after admission(T0),5 min after anesthesia(T1),before administration(T2),5 min after administration(T3),10 min after administration(T4),and at the end of the surgery(T5);recording the Ramsay sedation score at the end of surgery,neonatal outcomes,maternal postoperative status,and adverse reactions at T5.The Probit probability unit regression method was used to calculate the median effective dose(ED50)and 95%effective dose(ED95)of esketamine.Results The ED50 and 95%CI of esketamine for alleviating visceral traction pain during cesarean section were 0.151 mg/kg(0.114-0.184 mg/kg),the ED95 and 95%CI were 0.226 mg/kg(0.190-0.411 mg/kg).Compared to T0,the heart rate increased at T1 and decreased at T5(P<0.05);the blood pressure at T1 was lower than at T0,while the blood pressure at T3 was higher than at T1,T4,and T5(P<0.05).The Apgar scores of 27 newborns at 0,5,10 min were 9,10,and 10,the umbilical vein blood gas analysis showed that the pH was(7.35±0.04).No serious adverse reactions occurred in the statistical cases.Conclusion By Dixon sequential method and Probit probability unit regression method analysis,the ED50 and 95%CI of esketamine for alleviating visceral traction pain during cesarean section were 0.151 mg/kg(0.114-0.184 mg/kg),the ED95 and 95%CI were 0.226 mg/kg(0.190-0.411 mg/kg),respectively,which can provide reference for clinical precision medicine.
杨小敏;杨亮;王昀;胡祖荣
广东省妇幼保健院麻醉科,广州 511400广东省妇幼保健院麻醉科,广州 511400广东省妇幼保健院麻醉科,广州 511400广东省妇幼保健院麻醉科,广州 511400
艾司氯胺酮剖宫产牵拉痛半数有效剂量95%有效剂量
esketaminecesarean sectionvisceral traction painthe median effective dose95%effective dose
《麻醉安全与质控》 2026 (3)
223-228,6
广东省基础与应用基础研究基金(2023A1515220127)广东省妇幼保健院院内资助项目(20230026)
评论